Azerbaijan Kadar Faedah Keputusan
Bank Pusat Azerbaijan bertanggungjawab untuk membuat keputusan tentang kadar faedah di negara ini. Kadar Pembiayaan Semula adalah kadar faedah rasmi.
Angka yang lebih tinggi daripada yang dijangkakan harus dilihat sebagai positif (kenaikan) untuk AZN manakala angka yang lebih rendah daripada yang dijangkakan harus dilihat sebagai negatif (kemerosotan) untuk AZN.
Berita (AZN)
AstraZeneca Says AIRSUPRA Now Commercially Available In US As FDA-approved Option For Asthma
AstraZeneca (AZN, AZN.L) announces Monday that AIRSUPRA (albuterol/budesonide) is now commercially available in the US by prescription. AIRSUPRA was approved based on the results from two Phase III trials, MANDALA and DENALI.
RTTNews | 99 hari yang lalu
Compugen To Receive $10 Mln Payment After Dosing First Patient In AstraZeneca's ARTEMIDE-Bil01 Trial
Cancer immunotherapy company Compugen Ltd. (CGEN) announced Monday that Compugen is entitled to receive a $10 million milestone payment from British drug major AstraZeneca (AZN), after the first patient was dosed in AstraZeneca's ARTEMIDE-Bil01 trial with rilvegostomig.
RTTNews | 113 hari yang lalu
Allorion Therapeutic Inks Agreement With AstraZeneca For EGFR L858R Allosteric Inhibitor Program
Allorion Therapeutics, a US and China-based biotechnology company, on Tuesday entered into an exclusive option and global license agreement with British drug major AstraZeneca plc (AZN) to develop and commercialize a novel epidermal growth factor receptor (EGFR) L858R mutated allosteric inhibitor, as a potential new treatment for advanced EGFR-mutant non-small cell lung cancer (NSCLC).
RTTNews | 119 hari yang lalu
